Particulate, Specification Troubles Prompt Three Teva Recalls of Generic Tablets

Citing particulate and specification concerns, Teva is voluntarily recalling tens of thousands of bottles of generic hypertension drugs and five lots of generic oral contraceptives, the FDA says. The recalls are associated with three different products marketed by the Israeli-owned drugmaker’s U.S. subsidiary. Two were made at Teva plants, but one — metoprolol tartrate tablets USP 50 mg — was not, according to an enforcement report recently posted by the agency. The recall of the metoprolol tartrate tablets was initiated because some tablets did not conform to weight specifications, the report states. The 1,000-count bottles, each tagged with December 2013 expiration dates, were made by Emcure Pharmaceuticals at its Pune, India, plant.
Drug Industry Daily